Clinical Trial Update: Efficacy and Safety of Histamine Human Immunoglobulin in the Treatment of Chronic Spontaneous Urticaria (CSU) [Phase 4]

View source ↗

Summary

Phase 4 trial update on histamine human immunoglobulin for chronic spontaneous urticaria evaluating efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spontaneous Urticaria

Drugs mentioned

• Histamine Human Immunoglobulin

Snippet

Sponsor: Hangzhou Grand Biologic Pharmaceutical, Inc. | Conditions: Chronic Spontaneous Urticaria | Phase 4 | Status: UNKNOWN